TFBS Bioscience, Inc.(TW:6939)
NT$18.90-0.50 (-2.58%)
TW:6939
TFBS Bioscience, Inc. financials statements
NT$18.90
At close:-0.50 (-2.58%)
TFBS Bioscience, Inc. (6939) Income Statement
TFBS Bioscience, Inc. Income Statement
Last quarter (Q2 2026), TFBS Bioscience, Inc.'s total revenue was NT$90.28M, a decrease of 1.44% from the same quarter last year. In Q2, TFBS Bioscience, Inc.'s net income was NT$-31.38M. See TFBS Bioscience, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| NT$ 193.14M | NT$ 180.56M | NT$ 231.92M | NT$ 252.72M | NT$ 160.88M | |
| NT$ 36.82M | NT$ 37.52M | NT$ 63.32M | NT$ 104.05M | NT$ 54.05M | |
| NT$ 114.82M | NT$ 98.76M | NT$ 68.77M | NT$ 70.28M | NT$ 48.04M | |
| Depreciation and Amortization | NT$ 51.88M | NT$ 50.37M | NT$ 58.78M | NT$ 36.98M | NT$ 25.44M |
| NT$ -19.25M | NT$ 2.24M | NT$ 64.15M | NT$ 68.33M | NT$ 32.76M | |
| NT$ -78.00M | NT$ -61.23M | NT$ -5.45M | NT$ 33.77M | NT$ 6.01M | |
| NT$ 4.06M | NT$ 12.27M | NT$ 9.23M | NT$ -3.06M | NT$ 1.00M | |
| NT$ -73.94M | NT$ -48.97M | NT$ 4.77M | NT$ 30.71M | NT$ 7.01M | |
| NT$ -74.52M | NT$ -38.67M | NT$ 4.91M | NT$ 27.69M | NT$ 6.12M | |
| Per Share Metrics | |||||
| Basic EPS | NT$ -2.13 | NT$ -1.35 | NT$ 0.14 | NT$ 0.97 | NT$ 0.47 |
| Diluted EPS | NT$ -2.13 | NT$ -1.11 | NT$ 0.14 | NT$ 0.80 | NT$ 0.18 |
| Weighted Average Shares Outstanding | 34.94M | 28.65M | 35.06M | 28.65M | 12.96M |
| Weighted Average Shares Outstanding (Diluted) | 34.94M | 34.80M | 35.06M | 34.80M | 34.80M |
Currency in TWD

